Squarepoint’s Acceleron Pharma Inc. XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-13,193
| Closed | -$2.27M | – | 2976 |
|
|
2021
Q3 | $2.27M | Buy |
13,193
+11,451
| +657% | +$1.97M | 0.01% | 739 |
|
|
2021
Q2 | $219K | Sell |
1,742
-3,753
| -68% | -$472K | ﹤0.01% | 2167 |
|
|
2021
Q1 | $745K | Sell |
5,495
-4,604
| -46% | -$624K | ﹤0.01% | 1277 |
|
|
2020
Q4 | $1.29M | Buy |
10,099
+843
| +9% | +$108K | 0.01% | 941 |
|
|
2020
Q3 | $1.04M | Buy |
9,256
+1,968
| +27% | +$222K | 0.01% | 932 |
|
|
2020
Q2 | $694K | Sell |
7,288
-14,978
| -67% | -$1.43M | 0.01% | 1124 |
|
|
2020
Q1 | $2M | Buy |
22,266
+17,021
| +325% | +$1.53M | 0.05% | 434 |
|
|
2019
Q4 | $278K | Sell |
5,245
-4,406
| -46% | -$234K | ﹤0.01% | 2010 |
|
|
2019
Q3 | $381K | Sell |
9,651
-20,275
| -68% | -$800K | ﹤0.01% | 1696 |
|
|
2019
Q2 | $1.23M | Buy |
29,926
+4,247
| +17% | +$174K | 0.01% | 1125 |
|
|
2019
Q1 | $1.2M | Buy |
+25,679
| New | +$1.2M | 0.01% | 1009 |
|
|
2018
Q4 | – | Sell |
-17,651
| Closed | -$1.01M | – | 2337 |
|
|
2018
Q3 | $1.01M | Sell |
17,651
-8,549
| -33% | -$489K | 0.01% | 981 |
|
|
2018
Q2 | $1.27M | Buy |
26,200
+17,070
| +187% | +$828K | 0.02% | 802 |
|
|
2018
Q1 | $357K | Buy |
9,130
+3,931
| +76% | +$154K | 0.01% | 1231 |
|
|
2017
Q4 | $221K | Sell |
5,199
-3,282
| -39% | -$140K | ﹤0.01% | 1737 |
|
|
2017
Q3 | $317K | Buy |
+8,481
| New | +$317K | 0.01% | 1141 |
|
|
2017
Q2 | – | Sell |
-13,579
| Closed | -$359K | – | 1904 |
|
|
2017
Q1 | $359K | Sell |
13,579
-5,073
| -27% | -$134K | 0.01% | 999 |
|
|
2016
Q4 | $476K | Buy |
+18,652
| New | +$476K | 0.02% | 861 |
|
|
2016
Q1 | – | Sell |
-5,200
| Closed | -$254K | – | 1538 |
|
|
2015
Q4 | $254K | Buy |
+5,200
| New | +$254K | 0.03% | 875 |
|